Structures by: Abou A.
Total: 16
3-Hydroxy-3-methylisochroman-1-one--2-(carboxymethyl)benzoic acid (1/1)
C10H10O3,C9H8O4
IUCrData (2018) 3, 11 x181653
a=12.1143(4)Å b=9.81340(10)Å c=14.2602(2)Å
α=90° β=95.1160(10)° γ=90°
2-Oxo-2<i>H</i>-chromen-7-yl 4-methylbenzoate
C17H12O4
IUCrData (2018) 3, 7 x180927
a=5.7029(2)Å b=4.03460(10)Å c=28.9081(10)Å
α=90° β=90.751(3)° γ=90°
Coumarin
C16H9FO4
Acta Crystallographica Section E (2018) 74, 5 761-765
a=4.0181(2)Å b=5.7296(3)Å c=27.5566(14)Å
α=90° β=91.660(4)° γ=90°
Coumarin ester
C20H18O4
Acta Crystallographica Section E (2018) 74, 4 530-534
a=18.684(2)Å b=6.5431(5)Å c=13.6688(14)Å
α=90° β=93.627(11)° γ=90°
3-(2-Hydroxyethyl)-2-methylsulfanyl-6-nitro-3<i>H</i>-benzimidazol-1-ium chloride monohydrate
C10H12N3O3S,Cl,H2O
Acta crystallographica. Section E, Crystallographic communications (2016) 72, Pt 9 1356-1359
a=8.8587(5)Å b=22.1427(8)Å c=7.1657(2)Å
α=90° β=108.497(3)° γ=90°
3-(1H-Benzimidazol-2-ylsulfanyl)propan-1-ol
C10H12N2O1S1
Acta Crystallographica Section E (2007) 63, 11 o4463-o4463
a=7.1472(3)Å b=11.5574(6)Å c=12.5284(6)Å
α=90° β=98.343(4)° γ=90°
2-Methylsulfanyl-1-(morpholin-4-ylmethyl)-1H-benzimidazole
C13H17N3O1S1
Acta Crystallographica Section E (2007) 63, 11 o4218-o4218
a=6.2461(2)Å b=9.7949(2)Å c=11.6966(5)Å
α=75.4750(10)° β=84.8080(10)° γ=76.251(2)°
2-Benzylsulfanyl-1<i>H</i>-benzimidazole
C14H12N2S1
Acta Crystallographica Section E (2007) 63, 12 o4551-o4551
a=12.373(7)Å b=9.807(5)Å c=9.942(3)Å
α=90° β=91.084(3)° γ=90°
2-[2-(Methylsulfanyl)benzimidazol-1-yl]ethanol
C10H12N2O1S1
Acta Crystallographica Section E (2010) 66, 2 o442
a=9.3235(2)Å b=9.7659(2)Å c=11.4588(3)Å
α=78.0849(9)° β=88.9066(8)° γ=88.1399(9)°
4-hydroxycoumarin 4-methylbenzoate ester
C17H12O4
Acta Crystallographica Section E (2013) 69, 7 o1081-o1082
a=9.2790(5)Å b=10.7696(5)Å c=14.5758(9)Å
α=95.274(2)° β=97.875(2)° γ=104.788(5)°
2-Oxo-2<i>H</i>-chromen-4-yl 4-<i>tert</i>-butylbenzoate
C20H18O4
Acta Crystallographica Section E (2012) 68, 2 o537-o538
a=6.4319(2)Å b=9.3498(3)Å c=14.5505(5)Å
α=98.4810(10)° β=93.6550(10)° γ=102.359(2)°
4-hydroxycoumarin 4-methoxybenzoate ester
C17H12O5
Acta Crystallographica Section E (2012) 68, 12 o3438-o3439
a=4.3710(10)Å b=10.535(4)Å c=15.193(2)Å
α=85.218(3)° β=83.688(2)° γ=81.8930(10)°
2-Oxochromen-4-yl 4-(dimethylamino)benzoate
C18H15N1O4
Acta Crystallographica Section E (2011) 67, 9 o2269-o2270
a=7.4939(2)Å b=10.2361(3)Å c=10.6620(3)Å
α=92.307(3)° β=103.9350(10)° γ=109.852(2)°
4-[(4-Chlorophenyl)(hydroxy)methylidene]isochromane-1,3-dione
C16H9ClO4
Acta Crystallographica Section E (2011) 67, 12 o3349
a=15.4973(4)Å b=5.96310(10)Å c=14.4526(3)Å
α=90.00° β=102.6610(10)° γ=90.00°
4-[(Hydroxy)(4-methylphenyl)methylidene]isochroman-1,3-dione
C17H12O4
Acta Crystallographica Section E (2012) 68, 1 o3
a=15.6767(6)Å b=5.9655(2)Å c=14.4589(4)Å
α=90.00° β=102.9610(10)° γ=90.00°
2-Oxo-2<i>H</i>-chromen-4-yl propionic acid
C12H10O4
Acta Crystallographica Section E (2013) 69, 7 o1125-o1126
a=9.2834(3)Å b=6.7081(2)Å c=16.8068(6)Å
α=90.00° β=90.00° γ=90.00°